NasdaqGM:ATRCMedical Equipment
AtriCure (ATRC) Could Be 27% Undervalued Following Its Cardiac Device Growth Narrative
Recent Moves in AtriCure Stock
AtriCure (ATRC) has drawn attention after a recent stretch of positive returns over the past month and past 3 months, prompting investors to reassess how the stock currently prices its medical device business.
See our latest analysis for AtriCure.
Viewed over a longer stretch, AtriCure’s recent 30 day share price return of 19.81% and 90 day share price return of 24.88% sit against a year to date share price decline of 12.13% and a 1 year total shareholder return...